TYK2 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TYK2 inhibitor (unspecified), covering 2025-04-29 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Tyrosine Kinase 2 (TYK2) for GA and CS [Phase 2]